The present disclosure is directed to oxazoline mono- and hetero-pseudodimer compounds, such as compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: These compounds are useful for treating pain. The present disclosure also relates to pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of Formula (I) or (II) or a pharmaceutically acceptable salt or solvate thereof
本公开涉及
噁唑啉单聚体和异聚体化合物,例如公式(I)的化合物或其药用可接受盐或溶剂:这些化合物可用于治疗疼痛。本公开还涉及包括药用可接受载体和公式(I)或(II)的化合物或其药用可接受盐或溶剂的治疗有效量的药物组合物